During the past decade, NU-MED Centrum Diagnostyki i Terapii Onkologicznej conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "NU-MED Centrum Diagnostyki i Terapii Onkologicznej" are "Hodgkin's Lymphoma" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "NU-MED Centrum Diagnostyki i Terapii Onkologicznej" in a lesser frequency.

Most popular intervention types in "NU-MED Centrum Diagnostyki i Terapii Onkologicznej" are "Drug" (2 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (2 trials), "Atezolizumab" (1 trials), "Autologous Stem Cell Transplant" (1 trials), "Bendamustine" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "NU-MED Centrum Diagnostyki i Terapii Onkologicznej" are 2 trials for "All" genders.

Currently, there are NaN active trials in "NU-MED Centrum Diagnostyki i Terapii Onkologicznej". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in NU-MED Centrum Diagnostyki i Terapii Onkologicznej, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NU-MED Centrum Diagnostyki i Terapii Onkologicznej, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".